Rohan Palekar
2020
In 2020, Rohan Palekar earned a total compensation of $4.9M as Chief Executive Officer at 89bio, a 378% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $331,250 |
---|---|
Option Awards | $4,016,641 |
Salary | $530,000 |
Other | $8,402 |
Total | $4,886,293 |
Palekar received $4M in option awards, accounting for 82% of the total pay in 2020.
Palekar also received $331.3K in non-equity incentive plan, $530K in salary and $8.4K in other compensation.
Rankings
In 2020, Rohan Palekar's compensation ranked 2,275th out of 13,090 executives tracked by ExecPay. In other words, Palekar earned more than 82.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,275 out of 13,090 | 83rd |
Division Manufacturing | 872 out of 5,624 | 85th |
Major group Chemicals And Allied Products | 313 out of 2,257 | 86th |
Industry group Drugs | 265 out of 1,957 | 87th |
Industry Pharmaceutical Preparations | 189 out of 1,462 | 87th |
Source: SEC filing on April 15, 2021.
Palekar's colleagues
We found two more compensation records of executives who worked with Rohan Palekar at 89bio in 2020.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020